[1]李晓滨,白建云,赵启兵.右美托咪定对心肌缺血再灌注损伤大鼠的作用及机制研究[J].陕西医学杂志,2022,51(9):1060-1065.[doi:DOI:10.3969/j.issn.1000-7377.2022.09.004]
 LI Xiaobin,BAI Jianyun,ZHAO Qibing.Effect and mechanism of dexmedetomidine on myocardial ischemia-reperfusion injury in rats[J].,2022,51(9):1060-1065.[doi:DOI:10.3969/j.issn.1000-7377.2022.09.004]
点击复制

右美托咪定对心肌缺血再灌注损伤大鼠的作用及机制研究
分享到:

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
51
期数:
2022年9期
页码:
1060-1065
栏目:
基础研究
出版日期:
2022-09-05

文章信息/Info

Title:
Effect and mechanism of dexmedetomidine on myocardial ischemia-reperfusion injury in rats
作者:
李晓滨1白建云2赵启兵3
(1.宝鸡市中医医院麻醉手术科,陕西 宝鸡 721001; 2.榆林市第三医院麻醉科,陕西 榆林 719000; 3.安康市人民医院麻醉科,陕西 安康 725029)
Author(s):
LI XiaobinBAI JianyunZHAO Qibing
(Department of Anesthesiology and Surgery,Baoji Hospital of Traditional Chinese Medicine,Baoji 721001,China)
关键词:
心肌缺血再灌注损伤 右美托咪定 丝裂原活化蛋白激酶 氧化应激 内质网应激 大鼠
Keywords:
Myocardial ischemia-reperfusion injury Dexmedetomidine Mitogen-activated protein kinase Oxidative stress Endoplasmic reticulum stress Rat
分类号:
R 542.2
DOI:
DOI:10.3969/j.issn.1000-7377.2022.09.004
文献标志码:
A
摘要:
目的:探讨右美托咪定(Dex)对心肌缺血再灌注损伤(MIRI)大鼠的作用,并分析其机制。方法:将36只雄性SD大鼠随机分为对照组、MIRI模型组(MIRI组)和Dex治疗组(MIRI+Dex组),每组12只。MIRI组和MIRI+Dex组的24只大鼠用于建立MIRI模型。为研究miR-146a在Dex对MIRI大鼠心肌细胞作用中的机制,将心肌细胞分为 NC组(对照组大鼠心肌细胞)、抑制剂组(对照组大鼠心肌细胞转染miR-146a抑制剂)、MIRI+NC组(MIRI组大鼠心肌细胞)、MIRI+抑制剂组(MIRI组大鼠心肌细胞转染miR-146a抑制剂)、Dex+MIRI+NC组(MIRI+Dex组大鼠心肌细胞)和Dex+MIRI+抑制剂组(MIRI+Dex组大鼠心肌细胞转染miR-146a抑制剂)。为进一步验证丝裂原活化蛋白激酶(MAPK)信号通路是否参与了Dex对MIRI心肌细胞的作用机制,将心肌细胞分为对照组(仅用培养基处理大鼠心肌细胞)、SB组[p38 MAPK信号通路抑制剂SB203580(SB)0.5 μmol/L预处理2 h]、MIRI组(MIRI组大鼠心肌细胞)、MIRI+SB组(MIRI组大鼠心肌细胞用0.5 μmol/L SB预处理2 h)、Dex+MIRI组(MIRI+Dex组大鼠心肌细胞)和Dex+MIRI+SB组(MIRI+Dex组大鼠心肌细胞用0.5 μmol/L SB预处理2 h)。使用相应检测试剂盒测定乳酸脱氢酶(LDH)活性、超氧化物歧化酶(SOD)活性和丙二醛(MDA)水平。采用流式细胞术检测细胞凋亡率和活性氧(ROS)水平。使用定量实时PCR(qPCR)检测葡萄糖调节蛋白78(GRP78)、下游靶基因C/EBP家族同源蛋白(CHOP)、锰超氧化物歧化酶(MnSOD)、醌氧化还原酶1(NQO1)、过氧化氢酶(CAT)和miR-146a的mRNA相对表达量。结果:MIRI组miR-146a水平、SOD活性和细胞活力低于对照组,LDH活性、MDA水平、GRP78和CHOP水平、细胞凋亡率高于对照组(均P<0.05)。MIRI+Dex组miR-146a表达水平、SOD活性和细胞活力高于MIRI组,LDH活性、MDA水平、GRP78和CHOP水平、细胞凋亡率低于MIRI组(均P<0.05)。抑制剂组和MIRI+NC组细胞活力和miR-146a mRNA相对表达量明显低于NC组,Dex+MIRI+NC组细胞活力和miR-146a mRNA相对表达量高于Dex+MIRI+抑制剂组,而ROS水平表现出相反趋势(均P<0.05)。抑制剂组和MIRI+NC组GRP78、CHOP mRNA相对表达量高于NC组,MIRI+NC组低于MIRI+抑制剂组而高于Dex+MIRI+NC组,且Dex+MIRI+抑制剂组高于Dex+MIRI+NC组,而CAT、MnSOD、NQO1 mRNA相对表达量显示出相反趋势(均P<0.05)。MIRI组细胞活力低于对照组,但在MIRI+SB组和Dex+MIRI组中升高(均P<0.05)。MIRI组GRP78、CHOP mRNA相对表达量高于对照组,MIRI+SB和Dex+MIRI组则低于MIRI组(均P<0.05)。但Dex+MIRI+SB组GRP78 mRNA相对表达量低于Dex+MIRI组,CHOP mRNA相对表达量高于Dex+MIRI组(均P<0.05)。经SB预处理2 h后发现,抑制剂组细胞活力低于NC组,而抑制剂+SB组细胞活力高于抑制剂组(均P<0.05); 抑制剂组GRP78、CHOP mRNA相对表达量高于NC组和抑制剂+SB组(均P<0.05); 抑制剂+SB组GRP78、CHOP mRNA相对表达量低于抑制剂(均P<0.05)。结论:Dex可能通过调节miR-146a的表达,进一步调节内质网应激(ERS)和氧化应激,最终通过MAPK信号通路影响MIRI心肌细胞的细胞活力和凋亡。
Abstract:
Objective:To investigate the effect of dexmedetomidine(Dex)on myocardial ischemia-reperfusion injury(MIRI)in rats and analyze its mechanism.Methods:A total of 36 male SD rats were randomly divided into control group,MIRI model group(MIRI group)and Dex treatment group(MIRI+Dex group),with 12 rats in each group.Twenty-four rats in MIRI group and MIRI+Dex group were used to establish the MIRI model.In order to study the mechanism of miR-146a in the action of Dex on MIRI rat cardiomyocytes,cardiomyocytes were divided into NC group(rat cardiomyocytes in control group),inhibitor group(rat cardiomyocytes in control group were transfected with miR-146a inhibitor),MIRI+NC group(rat cardiomyocytes in MIRI group),MIRI+inhibitor group(rat cardiomyocytes in MIRI group were transfected with miR-146a inhibitor),Dex+MIRI+NC group(rat cardiomyocytes in MIRI+Dex group)and Dex+MIRI+inhibitor group(rat cardiomyocytes in MIRI+Dex group were transfected with miR-146a inhibitor).In order to further verify whether the mitogen-activated protein kinase(MAPK)signaling pathway was involved in the mechanism of Dex on MIRI cardiomyocytes,cardiomyocytes were divided into control group(rat cardiomyocytes was only treated with culture medium),SB group [rat cardiomyocytes were pretreated with 0.5 μmol/L p38 MAPK signaling pathway inhibitor SB203580(SB)for 2 hours],MIRI group(rat cardiomyocytes in MIRI group),MIRI+SB group(rat cardiomyocytes in MIRI group were pretreated with 0.5 μmol/L SB for 2 hours),Dex+MIRI group(rat cardiomyocytes in MIRI+Dex group)and Dex+MIRI+SB group(rat cardiomyocytes in MIRI+Dex group were pretreated with 0.5 μmol/L SB for 2 hours).Lactate dehydrogenase(LDH)activity,superoxide dismutase(SOD)activity,and malondialdehyde(MDA)levels were determined by using corresponding detection kits.Flow cytometry was performed to determine apoptosis rate and reactive oxygen species(ROS)level.Quantitative real-time PCR(qPCR)was used to detect the relative mRNA expression of GRP78,CHOP,MnSOD,NQO1,CAT and miR-146a.Results:MiR-146a level,SOD activity and cell viability in MIRI group were lower than those in control group,while LDH activity,MDA,GRP78 and CHOP levels,and apoptosis rate were higher than those in control group(all P<0.05).MiR-146a level,SOD activity and cell viability in MIRI+Dex group were higher than those in MIRI group,while LDH activity,MDA,GRP78 and CHOP levels,and apoptosis rate were lower than those in MIRI group(all P<0.05).The cell viability and relative expression of miR-146a mRNA in inhibitor group and MIRI+NC group were significantly lower than those in NC group,and the cell viability and relative expression of miR-146a mRNA in Dex+MIRI+NC group were higher than those in Dex+MIRI+inhibitor group,and the ROS level showed the opposite trend(all P<0.05).The relative mRNA expression levels of GRP78 and CHOP in inhibitor group and MIRI+NC group were higher than those in NC group,and those in MIRI+NC group were lower than those in MIRI+inhibitor group but higher than those in Dex+MIRI+NC group,and those in Dex+MIRI+inhibitor group were higher than those in Dex+MIRI+NC group,while the relative mRNA expression levels of CAT,MnSOD and NQO1 showed opposite trend(all P<0.05).Cell viability in MIRI group was lower than that in control group,but increased in MIRI+SB group and Dex+MIRI group(all P<0.05).The relative mRNA expression levels of GRP78 and CHOP in MIRI group were higher than those in control group,while those in MIRI+SB group and Dex+MIRI group were lower than those in MIRI group(all P<0.05).However,the relative mRNA expression level of GRP78 in Dex+MIRI+SB group was lower than that in Dex+MIRI group,and the relative mRNA expression level of CHOP was higher than that in Dex+MIRI group(all P<0.05).After pretreatment with SB for 2 hours,it was found that the cell viability of inhibitor group was lower than that of NC group,while that of inhibitor+SB group was higher than that of inhibitor group(all P<0.05).The relative mRNA expression levels of GRP78 and CHOP in inhibitor group were higher than those in NC group and inhibitor+SB group(all P<0.05).Conclusion:Dex may further regulate endoplasmic reticulum stress and oxidative stress by regulating the expression of miR-146a,and finally affect the cell viability and apoptosis of MIRI cardiomyocytes through the MAPK signaling pathway.

参考文献/References:

[1] 秦少博,黄增刚.缬沙坦/氨氯地平通过调控miR-21对心肌缺血/再灌注损伤大鼠的保护作用及机制研究[J].陕西医学杂志,2022,51(4):396-400,405.
[2] 马春香,孙 媛,陈晓斌,等.丹参酮ⅡA预处理对心肌缺血再灌注损伤保护作用的研究[J].陕西医学杂志,2017,46(10):1358-1359.
[3] 殷存芝,陈 慧,陈玉姣,等.JNK信号通路在右美托咪定预处理减轻大鼠离体心肌缺血再灌注损伤中的作用[J].重庆医学,2021,50(22):3786-3792.
[4] 王 辉,嵇富海,孟晓文,等.右美托咪定预处理对大鼠心肌缺血/再灌注损伤时心肌组织内质网应激的影响[J].国际麻醉学与复苏杂志,2020,41(8):737-741.
[5] 吴志林,朱 轶.右美托咪定通过Trx1/AMPK通路减轻心肌缺血再灌注损伤中的氧化应激[J].华中科技大学学报:医学版,2020,49(4):404-407.
[6] 白新华,李 卫.右美托咪定对心肌缺血-再灌注损伤大鼠的心肌保护作用[J].中国临床药理学杂志,2021,37(12):1566-1569,1585.
[7] Gao JM,Meng XW,Zhang J,et al.Dexmedetomidine protects cardiomyocytes against hypoxia/reoxygenation injury by suppressing TLR4-MyD88-NF-κB signaling[J].Biomed Res Int,2017,11(3):1-13.
[8] Chen Z,Ding T,Ma CG.Dexmedetomidine(DEX)protects against hepatic ischemia/reperfusion(I/R)injury by suppressing inflammation and oxidative stress in NLRC5 deficient mice[J].Biochem Biophys Res Commun,2017,493(2):1143-1150.
[9] Li Y,Liu S.The effect of dexmedetomidine on oxidative stress response following cerebral ischemia-reperfusion in rats and the expression of intracellular adhesion molecule-1(ICAM-1)and S100B[J].Med Sci Monit,2017,2(23):867-873.
[10] 任耀龙,杨 磊,赵明君,等.丹参饮预处理保护缺血/再灌注损伤模型大鼠心肌细胞实验研究[J].陕西中医,2021,42(6):692-695.
[11] 王全胜,艾热提,路菲菲.右美托咪定通过降低内质网应激改善大鼠肝缺血再灌注损伤[J].海南医学院学报,2019,25(5):330-334.
[12] 罗梓垠,郭长满,项冰倩,等.右美托咪定对肺缺血/再灌注损伤小鼠内质网应激相关分子Caspase-12表达的影响[J].中国应用生理学杂志,2016,32(2):164-168,后插3.
[13] 陈海明,杨 玲,薛凯凯.右美托咪定中枢远端干预对大鼠心肌缺血再灌注损伤的影响[J].山西医科大学学报,2019,50(5):533-536.
[14] 项冰倩,颜王鑫,高 慧,等.右美托咪定通过抑制内质网过度应激减轻肺缺血-再灌注小鼠脑损伤[J].中华急诊医学杂志,2017,26(11):1260-1267.
[15] 陈燕燕,徐 魏,向 力,等.右美托咪定对小鼠成肌细胞C2C12增殖、分化的影响[J].安徽医科大学学报,2020,55(9):1374-1380.
[16] 梁兆俊,冯娅妮,石 强.右美托咪定在大鼠蛛网膜下腔出血后对海马神经元炎性细胞因子的影响[J].中国药理学通报,2020,36(6):887-888.
[17] 张 勇.右美托咪定调控miR-146a对脓毒症小鼠急性肺损伤的保护作用及机制[D].济南:山东大学,2019.
[18] 车 昊,马 骏.右美托咪定对缺氧复氧诱导心肌细胞凋亡的防护作用及机制[J].中国医药,2021,16(5):758-762.
[19] 单阳阳,王 浩,刘洪涛.右美托咪定在神经损伤中的保护作用及分子机制[J].中国医师进修杂志,2018,41(1):74-77.
[20] 张世平,沈 鑫,李会玲,等.右美托咪定预处理对糖尿病大鼠心肌缺血-再灌注损伤的作用和机制[J].临床麻醉学杂志,2018,34(7):707-711.

相似文献/References:

[1]薛璋明,周绍文△,张 娟,等.羟考酮联合右美托咪定应用于区域麻醉镇静临床观察[J].陕西医学杂志,2020,49(2):231.
 XUE Zhangming,ZHOU Shaowen,ZHANG Juan,et al.Clinical observation of sedation under regional anesthesia with oxycodone combined with dexmedetomidine[J].,2020,49(9):231.
[2]杨 昊,郭 聪△.右美托咪定在降低老年腰椎手术患者术后认知功能障碍发生率中的应用[J].陕西医学杂志,2020,49(5):608.
 YANG Hao,GUO Cong..Application of dexmedetomidine in reducing the incidence of postoperative cognitive dysfunction in elderly patients undergoing lumbar surgery[J].,2020,49(9):608.
[3]张 祎,陈 权,尚 游.体温保护联合右美托咪定预防老年脊柱手术患者术后谵妄及寒战临床效果观察[J].陕西医学杂志,2021,50(3):308.[doi:DOI:10.3969/j.issn.1000-7377.2021.03.013]
[4]任学智,田芳玲,李 丹.七氟烷吸入全麻后持续泵入右美托咪定对腹腔镜胆囊切除患者镇痛效果研究[J].陕西医学杂志,2021,50(8):1007.[doi:DOI:10.3969/j.issn.1000-7377.2021.08.026]
[5]郭 聪,杨 昊.罗哌卡因复合不同剂量右美托咪定腹横肌平面阻滞对胃肠道腹腔镜手术患者镇痛及术后认知功能的影响[J].陕西医学杂志,2021,50(8):1011.[doi:DOI:10.3969/j.issn.1000-7377.2021.08.027]
 GUO Cong,YANG Hao.Effect of ropivacaine combined with different doses of dexmedetomidine in transversus abdominis plane block on intraoperative analgesia and the incidence of postoperative cognitive dysfunction in gastrointestinal laparoscopic surgery[J].,2021,50(9):1011.[doi:DOI:10.3969/j.issn.1000-7377.2021.08.027]
[6]单兆亚,王 波.右美托咪定调控急性痛风性关节炎模型大鼠血清炎性因子水平及滑膜功能效果研究[J].陕西医学杂志,2021,50(9):1052.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.003]
 SHAN Zhaoya,WANG Bo.Effect of dexmedetomidine on regulating serum inflammatory factors and synovial function in rats with acute gouty arthritis[J].,2021,50(9):1052.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.003]
[7]王 瑗,冯建梅,卫白杨.右美托咪定对坐骨神经慢性压迫损伤模型大鼠神经病理性疼痛的缓解作用及机制研究[J].陕西医学杂志,2021,50(12):1492.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.006]
 WANG Yuan,FENG Jianmei,WEI Baiyang.Alleviating effect and mechanism of dexmedetomidine on chronic neuropathic pain in rat model with chronic compression injury of sciatic nerve[J].,2021,50(9):1492.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.006]
[8]梁 赟,佘 濛,高子军,等.智能自控静脉镇痛泵用于腰椎后路融合术后患者镇痛效果研究[J].陕西医学杂志,2022,51(2):180.[doi:DOI:10.3969/j.issn.1000-7377.2022.02.012]
 LIANG Yun,SHE Meng,GAO Zijun,et al.Analgesic effect of smart-PCIA on patients after posterior lumbar fusion[J].,2022,51(9):180.[doi:DOI:10.3969/j.issn.1000-7377.2022.02.012]
[9]王兴程,张向宁,侯崇智,等.右美托咪定在脓毒症治疗中的作用及机制研究进展[J].陕西医学杂志,2022,51(3):382.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.028]
 WANG Xingcheng,ZHANG Xiangning,HOU Chongzhi,et al.Research progress on the role and mechanism of dexmedetomidine in the treatment of sepsis[J].,2022,51(9):382.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.028]
[10]陈金权,王 蕊.右美托咪定对慢性心力衰竭大鼠的作用及机制研究[J].陕西医学杂志,2022,51(6):664.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.005]
 CHEN Jinquan,WANG Rui.Effect and mechanism of dexmedetomidine on chronic heart failure in rats[J].,2022,51(9):664.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.005]

备注/Memo

备注/Memo:
基金项目:陕西省榆林市科协青年人才托举计划项目(20190109)
更新日期/Last Update: 2022-09-05